Another study by Laitman et al. came to a similar conclusion based on haplotype analyses of carriers from ethnically diverse backgrounds, which included Indians from Cochin, south India.31,32 Other founder BRCA1 and BRCA2 mutations were not detected in any of the Indian patients with breast and ovarian cancers, and no India-specific founder mutations were detected. This evidence concerns the gene BRCA2 and ovarian cancer.